Dolobid

Active Ingredient(s): Diflunisal
FDA Approved: * April 19, 1982
Pharm Company: * MERCK
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dolobid Overview

Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity. It was developed by Merck Sharp & Dohme in 1971, as MK647, after showing promise in a research project studying more potent chemical analogs of aspirin.[1] It was first sold under the brand name Dolobid, marketed by Merck & Co., but generic versions are now widely available. It is classed as a nonsteroidal anti-inflammatory drug (NSAID) and is available in 250mg and 500mg tablets. ...

Read more Dolobid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Diflunisal

Recent Dolobid Forums: RSS Feed

pill oblong blue 755|93

dont know ## This is generic Diflunisol(sp.) 500mg. It is generic for Dolobid. This is a non-narcotic medication typically used for osteoarthritis and rheumatoid arthritis. Look for bleeding, easy brusing, inability to pass urine, yellow eyes and or skin.

Updated

Possible Dosages for this and Related Drugs:

Diflunisal
  • Tablet: 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Diflunisal or a similar ingredient: (1 result)

Related Dolobid Topics:

dolobid 500 mg
anti inflamitory for arthritis ## Dolobid Info Click Here... 1 reply
Dolobid Monograh
DiflunisaL...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA